2020 Course Highlights



• Difficult cases in alcohol withdrawal

• Gabapentinoids: does the benefit really outweigh the risk?

• New guidelines on the management of opioid-induced constipation

• Dangers of natural / synthetic cannabinoids

• Lacing up: common contaminants of street drugs

• Kratom for cravings? A dangerous remedy for opiate withdrawal 

• Reducing recurrent opiate overdose at discharge 

• Pearls for managing acute pain in patients on chronic opioids 



• What to do when there is no allergist

• Managing aspirin hypersensitivity in acute coronary syndrome

• Biphasic reactions in anaphylaxis: fact and fiction

• A step-wise approach to suspected penicillin allergy



• Beyond diuresis in HF: what you need to know about ARNIs, SGLT2i, ivabradine, and IV iron

• New ACC/AHA guidelines for atrial fibrillation management  

• Are we overdoing dual-antiplatelet therapy after stenting? 

• P2Y12 inhibitors: choosing the best agent in acute coronary syndrome

• How much is enough? Complete vs. focused revascularization after MI 

• Colchicine after MI: not just for gout anymore? 

• Can your smartwatch diagnose atrial fibrillation? 

• Is sodium restriction in heart failure worth its salt? 

• New guidelines for venous thromboembolism 

• How high is too high? When to reverse a supratherapeutic INR with vitamin K 

• Think twice before stopping anticoagulation in unprovoked venous thromboembolism 

• New guidelines: diagnostic approach to recurrent syncope

• Transcatheter aortic valve replacement (TAVR): should we refer earlier in AS patients? 

• Difficult cases: overcoming diuretic resistance in heart failure



• Antipsychotics in delirium: less than we bargained for? 

• New data on anticholinergics, dementia, and delirium

• 16 melatonin and delirium trials: what's the verdict?

• Difficult cases in delirium management



• Rapid-fire review of electrolyte, liver, and heme cases

• Radiology pearls: identifying subtle findings on CXR

• Can't-miss ECG diagnoses

• Contrast or no contrast? Choosing the right imaging protocols



• Difficult cases in insulin management

• New FDA approval: automated insulin delivery in DM1

• Hypoglycemia close to discharge date: a marker for readmission and mortality 

• New data on the safety of SGLT2 inhibitors 

• Going to extremes: hypoglycemia risk rises with both high and low hemoglobin A1c 



• New guidelines: management of nonvariceal upper GI bleeding 

• Strategies for managing bleeding and thrombosis in the cirrhotic patient 

• Should more patients with severe alcoholic hepatitis get liver transplants? 

• How soon? Resuming anticoagulation and antiplatelet agents after a GI bleed

• Updated guidelines on management of biliary stones 

• Malabsorption after acute pancreatitis: an underdiagnosed complication



• Rapid-fire case review: working up anemia in the hospital

• Practical approach to IV iron repletion

• New data: DOAC use in chronic kidney disease and obesity 

• Choosing a DOAC after GI bleeding

• Anti-platelet antibodies: is there ever a reason to order them? 

• Red flags: when to call hematology? 



• COVID-19: lessons learned

• Intensive case-based review of inpatient antibiotics

• Pearls for interpreting culture and sensitivity data

• The Medicare sepsis bundle: is it evidence-based? 

• The positive MRSA nasal screen: to treat or not to treat?

• Newly approved antibiotics for highly resistant bacteria 

• Short course therapy for uncomplicated Gram-negative bacteremia 

• Reducing death in Staph aureus bacteremia 

• Early switch to oral antibiotics for MRSA bacteremia and endocarditis 

• Community-acquired C. difficile: no longer number two? 

• Unexpected benefits and hidden dangers of fecal transplants 

• Controversies in the new community-acquired pneumonia guidelines 

• New options for treating complicated UTIs

• Pearls for managing skin and soft tissue infections

• A checklist for inpatients with HIV



• New data: anticoagulation for post-op atrial fibrillation?

• Updates on perioperative anticoagulation, aspirin, ACE inhibitors, and beta blockers

• Are we undertreating osteoporosis in hip fracture patients?

• Endocarditis from non-dental procedures?

• New data on the importance of detecting perioperative MI



• Vaping-associated lung injury: what the hospitalist needs to know 

• C-reactive protein: better than procalcitonin for pneumonia management? 

• State-of-the-art treatment for asthma and COPD exacerbation

• Current recommendations for high-flow and supplemental O2



• Blood pressure management in end-stage renal disease

• Dialysis access: what the hospitalist needs to know

• New phosphate binders: pitfalls and promise

• New data on the GI toxicity of sodium polystyrene sulfonate

• Workup of acute glomerulonephritis



• Rapid-fire cases: rheumatologic emergencies and masqueraders

• Diagnostic pearls: exam, arthrocentesis, and serologies

• New options for acute gout attacks



• 2020 update: is the thrombolysis window now out to 9 hours? 

• Dual antiplatelet therapy in stroke and TIA 

• Primary prophylaxis for stroke in patients with atherosclerosis: another indication for DOACs?